Long QT Syndromes: Genetic Basis

Cardiac Electrophysiology Clinics

Volumn 4, Issue 1, 2012, Pages 1-16

  Schulze Bahr, Eric ^a,b,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Interdisciplinary Center for Clinical Research (IZKF)   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Gene; Ion channel; Long QT syndrome; Repolarization

Indexed keywords

CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; SYNTROPHIN;

ANDERSEN SYNDROME; AUTOPSY; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 21Q; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 7Q; DISEASE DURATION; ELECTROCARDIOGRAPHY; GAIN OF FUNCTION MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HEART DEPOLARIZATION; HEART REPOLARIZATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LONG QT SYNDROME; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; OUTCOME ASSESSMENT; PLURIPOTENT STEM CELL; PREVALENCE; PRIORITY JOURNAL; QT PROLONGATION; REVIEW;

EID: 84857086360     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2012.01.001     Document Type: Review

References (198)

1. Schwartz P.J., Stramba-Badiale M. Repolarization abnormalities in the newborn. J Cardiovasc Pharmacol 2010, 55(6):539-543.
2. Schwartz P.J., Stramba-Badiale M., Crotti L., et al. Prevalence of the congenital long-QT syndrome. Circulation 2009, 120(18):1761-1767.
3. Hayashi K., Fujino N., Uchiyama K., et al. Long QT syndrome and associated gene mutation carriers in Japanese children: results from ECG screening examination. Clin Sci (Lond) 2009, 117(12):415-424.
4. Kobza R., Roos M., Niggli B., et al. Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts. Heart Rhythm 2009, 6(5):652-657.
5. Brink P.A., Crotti L., Corfield V., et al. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation 2005, 112(17):2602-2610.
6. Marjamaa A., Salomaa V., Newton-Cheh C., et al. High prevalence of four long QT syndrome founder mutations in the Finnish population. Ann Med 2009, 41(3):234-240.
7. Piippo K., Swan H., Pasternack M., et al. A founder mutation of the potassium channel KCNQ1 in long QT syndrome - implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol 2001, 37(2):562-568.
8. Wang Q., Curran M.E., Splawski I., et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12(1):17-23.
9. Winbo A., Diamant U.B., Rydberg A., et al. Origin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutation. Heart Rhythm 2011, 8(4):541-547.
10. Itoh H., Shimizu W., Hayashi K., et al. Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm 2010, 7(10):1411-1418.
11. Yamaguchi M., Shimizu M., Ino H., et al. Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndrome. Clin Sci (Lond) 2005, 108(2):143-150.
12. Splawski I., Westenskow P., Timothy K., et al. Compound mutations - a common cause of severe Long QT syndrome. Circulation 2003, 108(17):182.
13. Larsen L.A., Fosdal I., Andersen P.S., et al. Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene. Eur J Hum Genet 1999, 7(6):724-728.
14. Ackerman M.J., Splawski I., Makielski J.C., et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004, 1(5):600-607.
15. Ackerman M.J., Tester D.J., Jones G.S., et al. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc 2003, 78(12):1479-1487.
16. Wang Q., Shen J., Splawski I., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995, 80(5):805-811.
17. Makita N., Behr E., Shimizu W., et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 2008, 118(6):2219-2229.
18. Takehara N., Makita N., Kawabe J., et al. A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med 2004, 255(1):137-142.
19. Huang H., Zhao J., Barrane F.Z., et al. Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes. Can J Cardiol 2006, 22(4):309-313.
20. Hwang H.W., Chen J.J., Lin Y.J., et al. R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J Med Genet 2005, 42(2):e7.
21. Makielski J.C., Ye B., Valdivia C.R., et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res 2003, 93(9):821-828.
22. Niu D.M., Hwang B., Hwang H.W., et al. A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect. J Med Genet 2006, 43(10):817-821.
23. Olszak-Waskiewicz M., Kubik L., Dziuk M., et al. The association between SCN5A, KCNQ1 and KCNE1 gene polymorphisms and complex ventricular arrhythmias in survivors of myocardial infarction. Kardiol Pol 2008, 66(8):845-853.
24. Poelzing S., Forleo C., Samodell M., et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 2006, 114(5):368-376.
25. Tan B.H., Valdivia C.R., Rok B.A., et al. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2005, 2(7):741-747.
26. Viswanathan P.C., Benson D.W., Balser J.R. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 2003, 111(3):341-346.
27. Ye B., Ackerman M.J., Makielski J.C. SCN5A can serve as its own modifier - a trafficking defective SCN5A arrhythmia mutation, M1766L, is corrected by the common polymorphism H558R. Circulation 2002, 106(19):225.
28. Splawski I., Timothy K.W., Tateyama M., et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002, 297(5585):1333-1336.
29. Kapa S., Tester D.J., Salisbury B.A., et al. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 2009, 120(18):1752-1760.
30. Schwartz P.J., Moss A.J., Vincent G.M., et al. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993, 88(2):782-784.
31. Rautaharju P.M., Surawicz B., Gettes L.S., et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009, 53(11):982-991.
32. Chiang A.Y., Bass A.S., Cooper M.M., et al. ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc). J Pharmacol Toxicol Methods 2007, 56(2):95-102.
33. Ackerman M.J., Priori S.G., Willems S., et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011, 8(8):1308-1339.
34. Viskin S., Sands A., Seltzer D., et al. Too many physicians cannot recognize a long QT when they see one. Circulation 2003, 108(17):426.
35. Wilde A.A., Brugada R. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res 2011, 108(7):884-897.
36. Goldenberg I., Thottathil P., Lopes C.M., et al. Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome. Heart Rhythm 2012, 9(1):49-56.
37. Darbar D. Triggers for cardiac events in patients with type 2 long QT syndrome. Heart Rhythm 2010, 7(12):1806-1807.
38. Kim J.A., Lopes C.M., Moss A.J., et al. Trigger-specific risk factors and response to therapy in long QT syndrome type 2. Heart Rhythm 2010, 7(12):1797-1805.
39. Sakaguchi T., Shimizu W., Itoh H., et al. Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J Cardiovasc Electrophysiol 2008, 19(8):794-799.
40. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103(1):89-95.
41. Jons C., Uchi J., Moss A.J., et al. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients. Sci Transl Med 2011, 3(76):76ra28.
42. Barsheshet A., Peterson D.R., Moss A.J., et al. Genotype-specific QT correction for heart rate and the risk of life threatening cardiac events in adolescents with the congenital long-QT syndrome. Heart Rhythm 2011, 8(8):1207-1213.
43. Bai R., Napolitano C., Bloise R., et al. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol 2009, 2(1):6-15.
44. Kapplinger J.D., Tester D.J., Salisbury B.A., et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009, 6(9):1297-1303.
45. Napolitano C., Priori S.G., Schwartz P.J., et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005, 294(23):2975-2980.
46. Keating M., Atkinson D., Dunn C., et al. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991, 252(5006):704-706. [see comments].
47. Wedekind H., Burde D., Zumhagen S., et al. QT interval prolongation and risk for cardiac events in genotyped LQTS-index children. Eur J Pediatr 2009, 168(9):1107-1115.
48. Tan H.L., Bardai A., Shimizu W., et al. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation 2006, 114(20):2096-2103.
49. Crotti L., Spazzolini C., Schwartz P.J., et al. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation 2007, 116(21):2366-2375.
50. Mikuni I., Torres C.G., Bienengraeber M.W., et al. Partial restoration of the long QT syndrome associated KCNQ1 A341V mutant by the KCNE1 beta-subunit. Biochim Biophys Acta 2011, 1810(12):1285-1293.
51. Li H., Chen Q., Moss A.J., et al. New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation 1998, 97(13):1264-1269.
52. Bartos D.C., Duchatelet S., Burgess D.E., et al. R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation. Heart Rhythm 2011, 8(1):48-55.
53. Lundby A., Ravn L.S., Svendsen J.H., et al. KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm 2007, 4(12):1532-1541.
54. Chen S., Zhang L., Bryant R.M., et al. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death. Clin Genet 2003, 63(4):273-282.
55. Bellocq C., van Ginneken A.C.G., Bezzina C.R., et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004, 109(20):2394-2397.
56. Imboden M., Swan H., Denjoy I., et al. Female predominance and transmission distortion in the long-QT syndrome. N Engl J Med 2006, 355(26):2744-2751.
57. Curran M.E., Splawski I., Timothy K.W., et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80(5):795-803.
58. Sanguinetti M.C., Jiang C., Curran M.E., et al. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995, 81(2):299-307.
59. Biliczki P., Girmatsion Z., Brandes R.P., et al. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction. Heart Rhythm 2009, 6(12):1792-1801.
60. Ficker E., Thomas D., Viswanathan P.C., et al. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am J Physiol Heart Circ Physiol 2000, 279(4):H1748-H1756.
61. Mihic A., Chauhan V.S., Gao X., et al. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation. PLoS One 2011, 6(3):e18273.
62. Anderson C.L., Delisle B.P., Anson B.D., et al. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 2006, 113(3):365-373.
63. Bhuiyan Z.A., Momenah T.S., Gong Q., et al. Recurrent intrauterine fetal loss due to near absence of HERG: clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation. Heart Rhythm 2008, 5(4):553-561.
64. Hoorntje T., Alders M., van Tintelen P., et al. Homozygous premature truncation of the HERG protein: the human HERG knockout. Circulation 1999, 100(12):1264-1267.
65. Johnson W.H., Yang P., Yang T., et al. Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome. Pediatr Res 2003, 53(5):744-748.
66. Teng G.Q., Zhao X., Lees-Miller J.P., et al. Homozygous missense N629D hERG (KCNH2) potassium channel mutation causes developmental defects in the right ventricle and its outflow tract and embryonic lethality. Circ Res 2008, 103(12):1483-1491.
67. Hong K., Bjerregaard P., Gussak I., et al. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 2005, 16(4):394-396.
68. Itoh H., Sakaguchi T., Ashihara T., et al. A novel KCNH2 mutation as a modifier for short QT interval. Int J Cardiol 2009, 137(1):83-85.
69. Brugada R., Hong K., Dumaine R., et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004, 109(1):30-35.
70. Bennett P.B., Yazawa K., Makita N., et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995, 376(6542):683-685.
71. Zimmer T., Surber R. SCN5A channelopathies-an update on mutations and mechanisms. Prog Biophys Mol Biol 2008, 98(2-3):120-136.
72. Clancy C.E., Tateyama M., Liu H., et al. Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia. Circulation 2003, 107(17):2233-2237.
73. Makiyama T., Akao M., Shizuta S., et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 2008, 52(16):1326-1334.
74. Benito B., Brugada R., Perich R.M., et al. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Heart Rhythm 2008, 5(10):1434-1440.
75. Surber R., Hensellek S., Prochnau D., et al. Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel. Cardiovasc Res 2008, 77(4):740-748.
76. Clancy C.E., Rudy Y. Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 2002, 105(10):1208-1213.
77. Veldkamp M.W., Viswanathan P.C., Bezzina C., et al. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ Res 2000, 86(9):E91-E97.
78. Ruan Y., Liu N., Bloise R., et al. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients. Circulation 2007, 116(10):1137-1144.
79. Shimizu W., Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997, 96(6):2038-2047.
80. Windle J.R., Geletka R.C., Moss A.J., et al. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A: DeltaKPQ mutation. Ann Noninvasive Electrocardiol 2001, 6(2):153-158.
81. Ruan Y., Denegri M., Liu N., et al. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. Circ Res 2010, 106(8):1374-1383.
82. Cheng J., Morales A., Siegfried J.D., et al. SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Clin Transl Sci 2010, 3(6):287-294.
83. Shinlapawittayatorn K., Du X.X., Liu H., et al. A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations. Heart Rhythm 2011, 8(3):455-462.
84. Hu D., Viskin S., Oliva A., et al. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm 2007, 4(8):1072-1080.
85. Stecker E.C., Sono M., Wallace E., et al. Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 2006, 3(6):697-700.
86. Tan B.H., Valdivia C.R., Song C., et al. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am J Physiol Heart Circ Physiol 2006, 291(4):H1822-H1828.
87. Schott J.J., Charpentier F., Peltier S., et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995, 57(5):1114-1122.
88. Mohler P.J., Schott J.J., Gramolini A.O., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421(6923):634-639.
89. Yang Y., Yang Y., Liang B., et al. Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet 2010, 86(6):872-880.
90. Sanguinetti M.C., Curran M.E., Zou A., et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996, 384(6604):80-83.
91. Barhanin J., Lesage F., Guillemare E., et al. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996, 384(6604):78-80. [see comments].
92. Splawski I., Tristani-Firouzi M., Lehmann M.H., et al. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997, 17(3):338-340.
93. Ohno S., Zankov D.P., Yoshida H., et al. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome. Heart Rhythm 2007, 4(3):332-340.
94. Wu D.M., Lai L.P., Zhang M., et al. Characterization of an LQT5-related mutation in KCNE1, Y81C: implications for a role of KCNE1 cytoplasmic domain in IKs channel function. Heart Rhythm 2006, 3(9):1031-1040.
95. Ma L., Lin C., Teng S., et al. Characterization of a novel long QT syndrome mutation G52R-KCNE1 in a Chinese family. Cardiovasc Res 2003, 59(3):612-619.
96. Schulze-Bahr E., Schwarz M., Hoffmann S., et al. A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype. J Mol Med 2001, 79(9):504-509.
97. Duggal P., Vesely M.R., Wattanasirichaigoon D., et al. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998, 97(2):142-146.
98. Bianchi L., Shen Z., Dennis A.T., et al. Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum Mol Genet 1999, 8(8):1499-1507.
99. Marx S.O., Kurokawa J., Reiken S., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295(5554):496-499.
100. Harmer S.C., Wilson A.J., Aldridge R., et al. Mechanisms of disease pathogenesis in long QT syndrome type 5. Am J Physiol Cell Physiol 2010, 298(2):C263-C273.
101. Zheng R., Thompson K., Obeng-Gyimah E., et al. Analysis of the interactions between the C-terminal cytoplasmic domains of KCNQ1 and KCNE1 channel subunits. Biochem J 2010, 428(1):75-84.
102. Chen J., Zheng R., Melman Y.F., et al. Functional interactions between KCNE1 C-terminus and the KCNQ1 channel. PLoS One 2009, 4(4):e5143.
103. Xu X., Jiang M., Hsu K.L., et al. KCNQ1 and KCNE1 in the IKs channel complex make state-dependent contacts in their extracellular domains. J Gen Physiol 2008, 131(6):589-603.
104. Seebohm G., Strutz-Seebohm N., Ureche O.N., et al. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels. Circ Res 2008, 103(12):1451-1457.
105. Seebohm G., Strutz-Seebohm N., Birkin R., et al. Regulation of endocytic recycling of KCNQ1/KCNE1 potassium channels. Circ Res 2007, 100(5):686-692.
106. Harmer S.C., Tinker A. The role of abnormal trafficking of KCNE1 in long QT syndrome 5. Biochem Soc Trans 2007, 35(Pt 5):1074-1076.
107. Li Y., Zaydman M.A., Wu D., et al. KCNE1 enhances phosphatidylinositol 4,5-bisphosphate (PIP2) sensitivity of IKs to modulate channel activity. Proc Natl Acad Sci U S A 2011, 108(22):9095-9100.
108. Melman Y.F., Um S.Y., Krumerman A., et al. KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity. Neuron 2004, 42(6):927-937.
109. Krapivinsky G., Gordon E.A., Wickman K., et al. The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins. Nature 1995, 374(6518):135-141.
110. Calloe K., Ravn L.S., Schmitt N., et al. Characterizations of a loss-of-function mutation in the Kir3.4 channel subunit. Biochem Biophys Res Commun 2007, 364(4):889-895.
111. Choi M., Scholl U.I., Yue P., et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011, 331(6018):768-772.
112. Chen L., Marquardt M.L., Tester D.J., et al. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A 2007, 104(52):20990-20995.
113. Kurokawa J., Motoike H.K., Rao J., et al. Regulatory actions of the A-kinase anchoring protein Yotiao on a heart potassium channel downstream of PKA phosphorylation. Proc Natl Acad Sci U S A 2004, 101(46):16374-16378.
114. Sesti F., Abbott G.W., Wei J., et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 2000, 97(19):10613-10618.
115. Abbott G.W., Sesti F., Splawski I., et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97(2):175-187.
116. Cui J., Kagan A., Qin D., et al. Analysis of the cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE2. J Biol Chem 2001, 276(20):17244-17251.
117. Isbrandt D., Friederich P., Solth A., et al. Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics. J Mol Med 2002, 80(8):524-532.
118. Pourrier M., Zicha S., Ehrlich J., et al. Canine ventricular KCNE2 expression resides predominantly in Purkinje fibers. Circ Res 2003, 93(3):189-191.
119. Pond A.L., Nerbonne J.M. ERG proteins and functional cardiac I(Kr) channels in rat, mouse, and human heart. Trends Cardiovasc Med 2001, 11(7):286-294.
120. Friederich P., Solth A., Schillemeit S., et al. Local anaesthetic sensitivities of cloned HERG channels from human heart: comparison with HERG/MiRP1 and HERG/MiRP1(T8A). Br J Anaesth 2004, 92(1):93-101.
121. Ueda K., Valdivia C., Medeiros-Domingo A., et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A 2008, 105(27):9355-9360.
122. Wu G., Ai T., Kim J.J., et al. α-1-Syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption. Circ Arrhythm Electrophysiol 2008, 1(3):193-201.
123. Cronk L.B., Ye B., Kaku T., et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 2007, 4(2):161-166.
124. Vatta M., Ackerman M.J., Ye B., et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006, 114(20):2104-2112.
125. Medeiros-Domingo A., Kaku T., Tester D.J., et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007, 116(2):134-142.
126. Gazzerro E., Bonetto A., Minetti C. Caveolinopathies translational implications of caveolin-3 in skeletal and cardiac muscle disorders. Handb Clin Neurol 2011, 101:135-142.
127. Mohler P.J., Splawski I., Napolitano C., et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A 2004, 101(24):9137-9142.
128. Sherman J., Tester D.J., Ackerman M.J. Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects. Heart Rhythm 2005, 2(11):1218-1223.
129. Curran J., Mohler P.J. Coordinating electrical activity of the heart: ankyrin polypeptides in human cardiac disease. Expert Opin Ther Targets 2011, 15(7):789-801.
130. Mohler P.J., Le Scouarnec S., Denjoy I., et al. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation 2007, 115(4):432-441.
131. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957, 54(1):59-68.
132. Chen Q., Zhang D., Gingell R.L., et al. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation 1999, 99(10):1344-1347.
133. Neyroud N., Tesson F., Denjoy I., et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997, 15(2):186-189. [see comments].
134. Schulze-Bahr E., Wang Q., Wedekind H., et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997, 17(3):267-268.
135. Tyson J., Tranebjaerg L., Bellman S., et al. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 1997, 6(12):2179-2185.
136. Schwartz P.J., Spazzolini C., Crotti L., et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006, 113(6):783-790.
137. Goldenberg I., Moss A.J., Zareba W., et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol 2006, 17(11):1161-1168.
138. Zhang S., Yin K., Ren X., et al. Identification of a novel KCNQ1 mutation associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long QT syndrome in a Chinese family. BMC Med Genet 2008, 9:24.
139. Bhuiyan Z.A., Momenah T.S., Amin A.S., et al. An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome. Prog Biophys Mol Biol 2008, 98(2-3):319-327.
140. Tawil R., Ptacek L.J., Pavlakis S.G., et al. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 1994, 35(3):326-330. [see comments].
141. Andelfinger G., Tapper A.R., Welch R.C., et al. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 2002, 71(3):663-668.
142. Davies N.P., Imbrici P., Fialho D., et al. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology 2005, 65(7):1083-1089.
143. Yoon G., Quitania L., Kramer J.H., et al. Andersen-Tawil syndrome: definition of a neurocognitive phenotype. Neurology 2006, 66(11):1703-1710.
144. Fodstad H.M., Swan H., Auberson M., et al. Mutations in the potassium channel gene KCNJ2 constitute a rare cause of long QT syndrome. Am J Hum Genet 2003, 73(5):557.
145. Tristani-Firouzi M., Jensen J.L., Donaldson M.R., et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002, 110(3):381-388.
146. Plaster N.M., Tawil R., Tristani-Firouzi M., et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001, 105(4):511-519.
147. Doi T., Makiyama T., Morimoto T., et al. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome. Circ Cardiovasc Genet 2011, 4(3):253-260.
148. Donaldson M.R., Jensen J.L., Tristani-Firouzi M., et al. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology 2003, 60(11):1811-1816.
149. Haruna Y., Kobori A., Makiyama T., et al. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome. Hum Mutat 2007, 28(2):208.
150. Sacconi S., Simkin D., Arrighi N., et al. Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes. Am J Physiol Cell Physiol 2009, 297(4):C876-C885.
151. Priori S.G., Pandit S.V., Rivolta I., et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005, 96(7):800-807.
152. Hattori T., Makiyama T., Akao M., et al. A novel gain-of-function KCNJ2 mutation associated with short QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc Res 2011, [Epub ahead of print].
153. Xia M., Jin Q., Bendahhou S., et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005, 332(4):1012-1019.
154. Reichenbach H., Meister E.M., Theile H. Kinderarztl Prax 1992, 60(2):54-56. [in German].
155. Marks M.L., Whisler S.L., Clericuzio C., et al. A new form of long QT syndrome associated with syndactyly. J Am Coll Cardiol 1995, 25(1):59-64.
156. Gillis J., Burashnikov E., Antzelevitch C., et al. Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of Timothy syndrome. Am J Med Genet A 2011, [Epub ahead of print].
157. Krause U., Gravenhorst V., Kriebel T., et al. A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8). Clin Res Cardiol 2011, 100(12):1123-1127.
158. Splawski I., Timothy K.W., Sharpe L.M., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119(1):19-31.
159. Etheridge S.P., Bowles N.E., Arrington C.B., et al. Somatic mosaicism contributes to phenotypic variation in Timothy syndrome. Am J Med Genet A 2011, 155(10):2578-2583.
160. Splawski I., Timothy K.W., Decher N., et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A 2005, 102(23):8089-8096.
161. Antzelevitch C., Pollevick G.D., Cordeiro J.M., et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007, 115(4):442-449.
162. Rottbauer W., Baker K., Wo Z.G., et al. Growth and function of the embryonic heart depend upon the cardiac-specific L-type calcium channel alpha1 subunit. Dev Cell 2001, 1(2):265-275.
163. Yazawa M., Hsueh B., Jia X., et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011, 471(7337):230-234.
164. Depil K., Beyl S., Stary-Weinzinger A., et al. Timothy mutation disrupts the link between activation and inactivation in Ca(V)1.2 protein. J Biol Chem 2011, 286(36):31557-31564.
165. Cheng E.P., Yuan C., Navedo M.F., et al. Restoration of normal L-type Ca2+ channel function during timothy syndrome by ablation of an anchoring protein. Circ Res 2011, 109(3):255-261.
166. Jacobs A., Knight B.P., McDonald K.T., et al. Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8). Heart Rhythm 2006, 3(8):967-970.
167. Yarotskyy V., Gao G., Peterson B.Z., et al. The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation. J Physiol 2009, 587(Pt 3):551-565.
168. Tester D.J., Ackerman M.J. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation 2011, 123(9):1021-1037.
169. Medeiros-Domingo A., Bhuiyan Z.A., Tester D.J., et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol 2009, 54(22):2065-2074.
170. Miller T.E., Estrella E., Myerburg R.J., et al. Recurrent third-trimester fetal loss and maternal mosaicism for long-QT syndrome. Circulation 2004, 109(24):3029-3034.
171. Crotti L., Lewandowska M.A., Schwartz P.J., et al. A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. Heart Rhythm 2009, 6(2):212-218.
172. Zhang L., Vincent G.M., Baralle M., et al. An intronic mutation causes long QT syndrome. J Am Coll Cardiol 2004, 44(6):1283-1291.
173. Murray A., Donger C., Fenske C., et al. Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation 1999, 100(10):1077-1084.
174. Barc J., Briec F., Schmitt S., et al. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. J Am Coll Cardiol 2011, 57(1):40-47.
175. Grilo L.S., Pruvot E., Grobety M., et al. Takotsubo cardiomyopathy and congenital long QT syndrome in a patient with a novel duplication in the Per-Arnt-Sim (PAS) domain of hERG1. Heart Rhythm 2010, 7(2):260-265.
176. Koopmann T.T., Alders M., Jongbloed R.J., et al. Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies. Heart Rhythm 2006, 3(1):52-55.
177. Eddy C.A., MacCormick J.M., Chung S.K., et al. Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. Heart Rhythm 2008, 5(9):1275-1281.
178. Tester D.J., Benton A.J., Train L., et al. Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. Am J Cardiol 2010, 106(8):1124-1128.
179. Oliva A., Brugada R., D'Aloja E., et al. State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol 2011, 32(1):1-16.
180. Basso C., Carturan E., Pilichou K., et al. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol 2010, 19(6):321-325.
181. Opdal S.H., Rognum T.O. Gene variants predisposing to SIDS: current knowledge. Forensic Sci Med Pathol 2011, 7(1):26-36.
182. Schwartz P.J., Priori S.G., Dumaine R., et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000, 343(4):262-267.
183. Schwartz P.J., Priori S.G., Bloise R., et al. Molecular diagnosis in a child with sudden infant death syndrome. Lancet 2001, 358(9290):1342-1343.
184. Wedekind H., Smits J.P., Schulze-Bahr E., et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 2001, 104(10):1158-1164.
185. Aurlien D., Leren T.P., Tauboll E., et al. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. Seizure 2009, 18(2):158-160.
186. Arnestad M., Crotti L., Rognum T.O., et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007, 115(3):361-367.
187. Wedekind H., Bajanowski T., Friederich P., et al. Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study. Int J Legal Med 2006, 120(3):129-137.
188. Ackerman M.J., Siu B.L., Sturner W.Q., et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001, 286(18):2264-2269.
189. Tu E., Bagnall R.D., Duflou J., et al. Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases. Brain Pathol 2011, 21(2):201-208.
190. Johnson J.N., Hofman N., Haglund C.M., et al. Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology 2009, 72(3):224-231.
191. Tester D.J., Dura M., Carturan E., et al. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm 2007, 4(6):733-739.
192. van der Werf C., Hofman N., Tan H.L., et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Heart Rhythm 2010, 7(10):1383-1389.
193. Choi G., Kopplin L.J., Tester D.J., et al. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 2004, 110(15):2119-2124.
194. Tester D.J., Medeiros-Domingo A., Will M.L., et al. Unexplained drownings and the cardiac channelopathies: a molecular autopsy series. Mayo Clin Proc 2011, 86(10):941-947.
195. Skinner J.R., Crawford J., Smith W., et al. Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm 2011, 8(3):412-419.
196. Behr E.R., Dalageorgou C., Christiansen M., et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 2008, 29(13):1670-1680.
197. Tan H.L., Hofman N., van Langen I.M., et al. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005, 112(2):207-213.
198. Stone J.R., Basso C., Baandrup U.T., et al. Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology. Cardiovasc Pathol 2012, 21(1):2-16.